Application of explainable reinforcement learning in optimal drug dosing: a case of warfarin
Abstract
Details
- Title: Subtitle
- Application of explainable reinforcement learning in optimal drug dosing: a case of warfarin
- Creators
- Sadjad Anzabi Zadeh
- Contributors
- W. Nick Street (Advisor)Barrett W. Thomas (Advisor)Qihang Lin (Committee Member)Kang Zhao (Committee Member)
- Resource Type
- Dissertation
- Degree Awarded
- Doctor of Philosophy (PhD), University of Iowa
- Degree in
- Business Administration (Business Analytics)
- Date degree season
- Summer 2023
- DOI
- 10.25820/etd.007071
- Publisher
- University of Iowa
- Number of pages
- xi, 87 pages
- Copyright
- Copyright 2023 Sadjad Anzabi Zadeh
- Language
- English
- Date submitted
- 07/24/2023
- Description illustrations
- Illustrations, tables, graphs, charts
- Description bibliographic
- Includes bibliographical references (pages 81-87).
- Public Abstract (ETD)
Warfarin, a blood clot preventive drug, poses dosing challenges due to its narrow therapeutic window, where excess causes bleeding and insufficiency raises clotting risks.
In this study, we employ the innovative Explainable Reinforcement Learning (XRL) technique to optimize warfarin dosing. Unlike traditional methods, XRL doesn’t require preexisting optimal dose examples, ensuring user-friendly outputs.
Our two-phase XRL framework begins with learning the optimal dose for patients via interaction with a mathematical model. In the subsequent phase, we extract optimal dosing, presented in an easy-to-read table format.
Successfully optimizing warfarin dosing in simulated patients, our framework is a crucial step towards XRL-based tools for medical decision-making. These tools promise improved care quality and reduced medical errors.
As we continue refining XRL’s potential, we anticipate safer and more efficient healthcare, transforming medical decision-making and enhancing patient outcomes.
- Academic Unit
- Tippie College of Business
- Record Identifier
- 9984454434802771